Mechanism of Zhizi Dahuang Decoction for anti-liver injury based on network pharmacology

ZHAO Jianfeng; CHEN Kai

doi:10.7619/jcmp.20223057

Journal of Clinical Medicine in Practice > 2022 > 26(22): 83-89. > DOI: 10.7619/jcmp.20223057

ZHAO Jianfeng, CHEN Kai. Mechanism of Zhizi Dahuang Decoction for anti-liver injury based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 83-89. DOI: 10.7619/jcmp.20223057

Citation:

PDF (3663 KB)

Mechanism of Zhizi Dahuang Decoction for anti-liver injury based on network pharmacology

ZHAO Jianfeng¹,
CHEN Kai^2, ,

1.
Hospital Office, Taixing Chinese Medicine Hospital, Taixing, Jiangsu, 225400
2.
Department of Pharmacy, Taizhou School of Clinical Medicine of Nanjing Medical University, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, Jiangsu, 225300

More Information

Received Date: October 07, 2022
Available Online: December 01, 2022

Graphical Abstract

Abstract

Abstract

Objective
To explore the potential mechanism of Zhizi Dahuang Decoction in the prevention and treatment of liver injury based on network pharmacology.
Methods
The chemical constituents of each herb in Zhizi Dahuang Decoction were retrieved from the databases and then subjected to preliminary screening; the potential action targets of Zhizi Dahuang Decoction and the therapeutic targets for liver injury were collected. After taking the intersection, the composition-target interaction was analyzed, the protein-protein interaction (PPI) network was constructed, and the key target genes were screened. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were carried out to determine the key action targets and pathways of Zhizi Dahuang Decoction in the treatment of liver injury. Finally, the binding activity of key constituents to key targets was assessed by molecular docking.
Results
A total of 71 phytochemical components were identified as potential active components from Zhizi Dahuang Decoction. A total of 47 intersection targets were generated after 341 disease-related targets were intersected with 138 compound targets. After further screening, seven key target genes of Zhizi Dahuang Decoction in the treatment of liver injury were obtained, including tumor necrosis factor (TNF), heme oxygenase-1 (HMOX1), interleukin-6 (IL6), mitogen-activated protein kinase 8 (MAPK8), prostaglandin intra peroxidase synthase 2 (PTGS2), and heat shock protein 90 alpha family class A member 1 (HSP90AA1) and Caspase 3 (CASP3). GO and KEGG pathway analysis showed that Zhizi Dahuang Decoction could reduce the level of lipid peroxidation in the liver and increase the level of antioxidant enzymes, thereby exerting an anti-oxidative stress effect; it could also play an anti-inflammatory effect by inhibiting the TNF signaling pathway. The molecular docking results showed that the three key active components in the Zhizi Dahuang Decoction had a very high binding activity to the key proteins(emodin-TNF, aloe emodin-HSP90AA1, obakunone-CASP3).
Conclusion
Zhizi Dahuang Decoction could exert its medicinal effect on liver injury by inhibiting oxidative stress, inflammatory response and hepatocyte apoptosis.
- Zhizi Dahuang Decoction,
- liver injury,
- mechanism,
- network pharmacology,
- molecular docking,
- targets

FullText(HTML)

References (18)

References

[1]	尚炽昌, 王付. 经方配伍用药指南[M]. 北京: 中国中医药出版社, 1998: 25-35.
[2]	许阳贤, 杨吉勇, 曹锦峰. 栀子大黄汤利胆抗炎作用的实验研究[J]. 江苏中医药, 2013, 15(9): 74-75. doi: 10.3969/j.issn.1672-397X.2013.09.046
[3]	陈明丽. 栀子大黄汤加减联合双歧杆菌三联活菌肠溶胶囊、蓝光照射治疗新生儿病理性黄疸的效果[J]. 医学信息, 2021, 34(24): 154-156. doi: 10.3969/j.issn.1006-1959.2021.24.040
[4]	魏雯佳, 王树民, 丁娅. 栀子大黄汤合柴胡疏肝散治疗黄疸型肝炎的临床观察[J]. 中国中医药科技, 2019, 26(4): 593-595. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYY201904048.htm
[5]	杨柳, 张王宁, 刘月涛, 等. 基于网络药理学的黄芪治疗肾病综合征的机制研究[J]. 中草药, 2019, 50(8): 1828-1837. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201908010.htm
[6]	甘丽华, 李志敏, 何泉, 等. 基于分子对接技术与网络药理学分析方法的半夏-黄连药对治疗胃食管反流病的作用机制研究[J]. 实用临床医药杂志, 2021, 25(21): 1-6. doi: 10.7619/jcmp.20211655
[7]	覃薇, 殷梓辛, 华维维, 等. 基于网络药理学和分子对接探讨通关藤治疗胃癌的作用机制[J]. 实用临床医药杂志, 2022, 26(1): 1-7, 17. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202201001.htm
[8]	褚晓文, 韩飞, 宋爱华, 等. 基于HPLC-FT-ICR MS技术的栀子大黄汤在大鼠胆汁中原形成分及代谢产物的分析鉴定[J]. 沈阳药科大学学报, 2019, 36(11): 998-1010, 1040. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD201911008.htm
[9]	ZHU H, BI K, HAN F, et al. Identification of the absorbed components and metabolites of Zhi-Zi-Da-Huang Decoction in rat plasma by ultra-high performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry[J]. J Pharm Biomed Anal, 2015, 111: 277-287. doi: 10.1016/j.jpba.2015.03.043
[10]	高雨, 朱琦, 陈蕾蕾, 等. 栀子主要有效成分的代谢及毒性研究进展[J]. 中南药学, 2021, 19(2): 254-260. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX202102014.htm
[11]	屈义虎. 药用大黄成分分析及结合型蒽醌生物转化研究[D]. 汉中: 陕西理工大学, 2019.
[12]	刘李婷, 石菲, 刘叶, 等. 不同豆制品中大豆异黄酮的种类和含量分析[J]. 食品安全导刊, 2022(19): 100-102. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAQ202219035.htm
[13]	童培珍, 李国卫, 何嘉莹, 等. 基于指纹图谱和多指标成分含量测定的枳壳与枳实药材质量差异性研究[J]. 中南药学, 2022, 20(4): 898-904. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX202204026.htm
[14]	GADD V L, ALEKSIEVA N, FORBES S J. Epithelial plasticity during liver injury and regeneration[J]. Cell Stem Cell, 2020, 27(4): 557-573.
[15]	唐颖慧, 刘皎皎, 李粉萍, 等. 急性药物性肝损伤患者中医证候要素分布特征探讨[J]. 实用临床医药杂志, 2022, 26(7): 8-12. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202207002.htm
[16]	刘天凤, 马丽, 李艳婷, 等. 栀子大黄汤抗肝内胆汁淤积有效部位的筛选及其化学成分分析[J]. 沈阳药科大学学报, 2017, 34(8): 644-653. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD201708006.htm
[17]	李伦, 钟伟超, 梁伟海, 等. 栀子大黄汤对四氯化碳致小鼠急性肝损伤的保护作用[J]. 中国实验方剂学杂志, 2016, 22(12): 108-112. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201612022.htm
[18]	张晓书, 韩飞, 朱鹤云, 等. 栀子大黄汤抗酒精性肝损伤的体内外实验[J]. 沈阳药科大学学报, 2016, 33(7): 565-571. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYD201607011.htm

[1]	MA Jing, JIA Tianfeng, MAO Haifei, YANG Jihong. Mechanism of "treating different diseases with the same method" for chronic obstructive pulmonary disease and diabetes with Shenling Baizhu San based on network pharmacology and molecular docking[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 38-45. DOI: 10.7619/jcmp.20244292
[2]	LU Junwei, ZHU Jingzhe, CHEN Hongru, XIE Jumin. Molecular mechanism of luteolin in treatment of cervical cancer based on network pharmacology and molecular docking technology[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 26-33. DOI: 10.7619/jcmp.20241525
[3]	YANG Hui, XIONG Yuan, CHENG Long, QIAN Ming, JI Li. Mechanism of Dengzhan Shengmai capsule in treating coronary heart disease based on network pharmacology and molecular docking technology[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 1-8, 14. DOI: 10.7619/jcmp.20240541
[4]	DENG Jialin, QIAN Yayun, YANG Niuniu. Prediction of the mechanism of Dictamni Cortex in treating dermatitis, eczema and psoriasis based on "the same treatment for different diseases"[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 108-114, 119. DOI: 10.7619/jcmp.20231043
[5]	LIU Mingyue, YANG Yumei, ZHENG Yanze. Network pharmacology of main pharmacological components of Chuanxiong-Danshen drug pair and its fingerprints[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 98-103. DOI: 10.7619/jcmp.20230668
[6]	JIN Xuening, LIN Fei, FENG Xinyi, LI Cen, CUI Shu′na. Mechanism of docetaxel in treatment of choriocarcinoma based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 18-21. DOI: 10.7619/jcmp.20213494
[7]	QIN Wei, YIN Zixin, HUA Weiwei, WANG Yujie, WANG Yang, DENG Jialin, CAI Zhaoying, QIAN Yayun. Mechanisms of Marsdenia tenacissima in inhibiting gastric cancer based on network pharmacologyand molecular docking technology[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 1-7,17. DOI: 10.7619/jcmp.20213297
[8]	GAN Lihua, LI Zhimin, HE Quan, YANG Kun, GUO Chaofeng. Study on the mechanism of herbal pair of Banxia-Huanglian in treatment of gastroesophageal reflux disease based on molecular docking and network pharmacology[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 1-6. DOI: 10.7619/jcmp.20211655
[9]	LI Hui, CAO Boya, REN Lutong, WEI Ziying, LI Jiayi, GUO Yuanyuan, WANG Wei, CAO Junling. Exploration on therapeutic mechanisms of Zhishangfeng Granules for common cold based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 18-23, 41. DOI: 10.7619/jcmp.20211607
[10]	WANG Lei, CHEN Kun. Analysis in mechanism of Taohong Siwu Decoction in the treatment of femoral head necrosis based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 10-15,19. DOI: 10.7619/jcmp.20200915

Cited By

Cited by

Periodical cited type(5)

1.	蒋志达，张斌. 通督健脑针法联合固本宣肺方辅助治疗急性脑卒中相关性肺炎疗效观察. 山西中医. 2022(01): 38-41 .
2.	任向利，任向杰，马雪静，刘肇玮，白玉. 血清血红蛋白清道夫受体可溶性CD163联合中性粒细胞与淋巴细胞比值预测卒中相关性肺炎患者预后的价值. 实用临床医药杂志. 2022(02): 18-22 . 本站查看
3.	蒋和平，王劢，吴国荣，王丽东. 血清缺氧诱导因子-1α、肾上腺髓质素前体、甘胆酸水平与老年慢性阻塞性肺疾病急性加重期患者肺功能损伤进展的相关性. 实用临床医药杂志. 2022(05): 122-126 . 本站查看
4.	许江飞，周海燕，王宽红. 急性缺血性脑卒中相关性肺炎患者耐药性分析. 河南医学高等专科学校学报. 2022(02): 135-139 .
5.	张莹，张倩春，姜瑜. 血清pro-ADM、pro-AVP/CPP动态监测评估ICU重症社区获得性肺炎患者预后价值分析. 实验与检验医学. 2020(06): 1153-1158 .

Other cited types(0)

Get Citation

PDF

XML

Article views (261) PDF downloads (18) Cited by(5)

Turn off MathJax

Article Contents

Abstract

References

Mechanism of Zhizi Dahuang Decoction for anti-liver injury based on network pharmacology